Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM

1.70 Up 0.08(4.94%) 4:00PM EDT|After Hours : 1.71 Up 0.01 (0.59%) 4:39PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 30, 2013Oct 30, 2012Jul 30, 2012Apr 29, 2012
Total Revenue 7,039   6,139   4,251   2,065  
Cost of Revenue3,651  3,703  2,024  934  
Gross Profit 3,388   2,436   2,227   1,131  
Operating Expenses
Research Development5,437  6,053  6,981  8,930  
Selling General and Administrative3,112  3,440  2,917  3,091  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,161) (7,057) (7,671) (10,890)
Income from Continuing Operations
Total Other Income/Expenses Net255  (1,652)8  10  
Earnings Before Interest And Taxes(4,906)(7,013)(7,663)(10,880)
Interest Expense8  44  1  2  
Income Before Tax(4,914)(7,057)(7,664)(10,882)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,914)(8,753)(7,664)(10,882)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,914) (8,753) (7,664) (10,882)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,914) (8,753) (7,664) (10,882)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.